Dr. Sudip Mukherjee

Assistant Professor
Department/School/Unit Name
School of Biomedical Engineering IIT(BHU)
Phone No(s): 7980659213
Email: sudip.bme@iitbhu.ac.in
Area of Interest: Cell and Tissue Engineering, Cell Therapy in Diabetes and Cancer, Rare Genetic Disorders, Immunomodulation, Antifibrosis, Immunoprotection to medical implants, Biomaterials, Diabetic wound healing, Nanomedicine, Angiogenesis

Sudip Mukherjee, Ph.D., MRSC, is an Assistant Professor of School of Biomedical Engineering at the Indian Institute of Technology, BHU (IIT BHU). Dr. Mukherjee completed his Ph.D. from CSIR-IICT, Hyderabad in 2017, following which he worked at Rice University, Houston till 2022 as a postdoctoral research associate. His research interests include the development of advanced biomaterials for cell therapy and drug/gene delivery in diabetes, rare genetic disorders (Gaucher's disease, Hemophilia, Duchene muscular dystrophy, lysosomal disorders etc), fibrosis, tissue regeneration, cancer theranostics, angiogenesis, and immunomodulatory applications. He has published over 60 research (Nature Biomedical Engineering, Advanced Materials, Science Advances, Theranostics, Chemical Science etc) and review papers with total citations over 5500 with 'h' index of '38' and 'i' index of '57'. Dr. Mukherjee has 14 US patents filed/granted, multiple technologies (LOCOcyte) licensed and has been part of cell engineering-based therapies that are currently under clinical trials (Phase I/II) for advanced peritoneal cancers. Dr. Mukherjee received several awards including Houston Methodist-Rice University travel grant, KVRAO young scientist award, multiple best poster awards etc. Dr. Mukherjee serves as an Associate Editor for BMC Cancer and Frontiers in Chemistry and a member of Royal Society of Chemistry (RSC), UK; American Chemical Society (ACS), USA and Society for Biomaterials and Artificial Organs, India. In 2020-2023, Dr. Mukherjee has been included in the prestigious list of World's Top 2% scientist jointly published by the Stanford University and Elsevier for consecutive four times.

The Mukherjee Lab (Biomaterials and Cell Engineering) is focused on developing transformative technologies in the interface of Cell Engineering and Tissue Engineering. His research is involved in the development of advanced biomaterials for drug delivery in cancer theranostics, immunomodulatory applications & angiogenesis. Currently he is working to develop novel cell therapeutic solution in Cancer and Diabetes using various cell encapsulated biomaterials. The therapeutic cells utilized are included but not limited to islets cells, cytokine producing cells, stem cells, endothelial cells etc. Further, his research interest is focused on the development of novel and innovative immunomodulatory nanomaterials/biomaterials/polymers for cell therapy, drug delivery, improved tumor targeting, and immunomodulatory applications in diabetes and cancers. These are the following area the lab is currently focusing:

1. Development of vascularized scaffolds for the delivery of islets to cure Type-1 diabetes.
2. Developing engineered cell therapy for Diabetic wound healing applications and Cancers.
3. Discovery of novel small molecules for anti-fibrosis applications to medical implants.
4. Developing cell-engineered technologies for rare genetic disorders (Cystic Fibrosis, Lysosomal Disorder, Gaucher disease type 1, Muscle Dystrophy, Hemophilia etc).
5. Multifunctional nanomedicine in cancer theranostics and anti-bacterial applications.

2022 (June) - Present: Assistant Professor at School of Biomedical Engineering, IIT (BHU), Varanasi, UP, India. 

2023 (November) - Visiting Scholar, Sakura Exchange Program, Niigata University, Japan

2022 (July) – 2023 (July): Visiting Scientist at Department of Bioengineering, Rice University, Houston, TX, USA.

2021 (July) - 2022 (July): Research Scientist at Department of Bioengineering, Rice University, Houston, TX, USA.

2017 (July) - 2021 (June): Postdoctoral Research Associate at Department of Bioengineering, Rice University, Houston, TX, USA.

2012 (January) - 2017 (May): Ph.D. Scholar (CSIR rank# 014) at CSIR-Indian Institute of Chemical Technology, Hyderabad, India. 

Research articles: (‪https://scholar.google.com/citations?user=LFRX27EAAAAJ‬)

  1. Devyani Yenurkar, Maria Ruocco, Pragya Pragya, Lily Liang, Sudip Mukherjee*. Small molecule conjugation reduces macrophage uptake and increases in vivo blood circulation of polystyrene nanoparticles. Biomedical Materials, 2024, DOI: 10.1088/1748-605X/ad1df8. [*Corresponding author]
  2. Sudip Mukherjee, Boram Kim, Lauren Cheng, Michael Doerfert, Jiaming Li, Andrea Hernandez, Lily Liang, Maria Ruocco, Peter Rios, Sofia Ghani, Ira Joshi, Douglas Isa, Trisha Ray, Tanguy Terlier, Cody Fell, Ping Song, Roberto Miranda, Jose Oberholzer, David Zhang, Omid Veiseh. Screening hydrogels for antifibrotic properties by implanting cellularly barcoded alginates in mice and a non-human primate. Nature Biomedical Engineering, 2023, 7(7), 867–886, https://doi.org/10.1038/s41551-023-01016-2.
  3. Christian C. Schreib, Maria I. Jarvis, Tanguy Terlier, Jacob Goell, Sudip Mukherjee, Michael D. Doerfert, Taylor Anne Wilson, Michael Beauregard, Kevin N. Martins, Jared Lee, Leo Sanchez Solis, Esperanza Vazquez, Matthias A. Oberli, Brian W. Hanak, Michael Diehl, Isaac Hilton, Omid Veiseh. Lipid deposition profiles influence foreign body responses. Advanced Materials, 2023, https://doi.org/10.1002/adma.202205709.
  4. Sourav Das, Sanchita Tripathy, Bojja Sreedhar, Sudip Mukherjee,* Chitta Ranjan Patra.* Design of Lysozyme‐templated Biocompatible Fluorescent Nanocomposites and Their Potential Applications for Cell Imaging, Hydrogen Peroxide Sensing and Cancer Therapy. Advanced Therapeutics, 2023, DOI: 10.1002/adtp.202200293. [*Corresponding author]
  5. Kirti Wasnik, Prem Shankar Gupta, Sudip Mukherjee, Alagu Oviya, Ravi Prakash, Divya Pareek, Sukanya Patra, Somedutta Maity, Vipin Rai, Monika Singh, Gurmeet Singh, Desh Deepak Yadav, Santanu Das, Pralay Maiti, Pradip Paik. Poly(N-acryloylglycine-acrylamide) Hydrogel Mimics the Cellular Microenvironment and Promotes Neurite Growth with Protection from Oxidative Stress. ACS Applied Bio Materials, 2023, https://doi.org/10.1021/acsabm.3c00807.
  6. Siavash Parkhideh, Gisele A. Calderon, Kevin D. Janson, Sudip Mukherjee, A. Kristen Mai, Michael D. Doerfert, Zhuoran Yao, Daniel W. Sazer and Omid Veiseh. Perfusable cell-laden matrices to guide patterning of vascularization in vivo. Biomaterials Science, 2023, DOI: 10.1039/D2BM01200F.
  7. Sarah J. Karinja, Jaime L. Bernstein, Sudip Mukherjee et al. An Anti-Fibrotic Breast Implant Surface Coating Significantly Reduces Peri-Prosthetic Capsule Formation. Plastic and Reconstructive Surgery, 2023, DOI: 10.1097/PRS.0000000000010323.
  8. Matthew A Wright, Andrew J Miller, Xue Dong, Sarah J Karinja, Arash Samadi, Daniel O Lara, Sudip Mukherjee, Omid Veiseh, Jason A Spector. Reducing Peri-Implant Capsule Thickness in Submuscular Rodent Model of Breast Reconstruction with Delayed Radiotherapy. Journal of Surgical Research, 2023, 291, 158-166.
  9. Nash, A.M., Jarvis, M.I., Aghlara-Fotovat, S., Mukherjee, S., et al. Clinically Translatable Cytokine Delivery Platform for Eradication of Intraperitoneal Tumors. Science Advances, 2022, 8(9): p. eabm1032.
  10. Satish Kumar Vemuri, Satyajit Halder, Rajkiran Reddy Banala, Hari Krishnreddy Rachamalla, Vijaya Madhuri Devraj, Chandra Shekar Mallarpu, Uttam Kumar Neerudu, Ravikiran Bodlapati, Sudip Mukherjee, Subbaiah Goli Peda Venkata, Gurava Reddy Annapareddy Venkata, Malarvilli Thakkumalai, Kuladip Jana, Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways—In Vitro and In Vivo Studies. International Journal of Molecular Sciences, 2022, 23(4): p. 2150.
  11. Mukherjee, S.,* Bollu, V.S., Roy, A., Nethi, S.K., Madhusudana, K., Kumar, J.M., Sistla, R. and Patra, C.R.*, Acute Toxicity, Biodistribution, and Pharmacokinetics Studies of Pegylated Platinum Nanoparticles in Mouse Model. Advanced NanoBiomed Research, 2021, 1(7): p. 2000082. [*Corresponding author]  
  12. Haque, S., Norbert, C.C., Acharyya, R., Mukherjee, S., Kathirvel, M. and Patra, C.R.,* Biosynthesized silver nanoparticles for cancer therapy and in vivo bioimaging. Cancers, 2021, 13(23): p. 6114.
  13. Mukherjee, S., et al. Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma. Materials Science and Engineering: C, 2020, 108: p.110375.
  14. Ravi K Ghanta, Samira Aghlara-Fotovat, Aarthi Pugazenthi, Christopher T. Ryan, Vivek P. Singh, Megumi Mathison, Maria I. Jarvis, Sudip Mukherjee, Andrea Hernandez, Omid Veiseh. Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium. Biomaterials science, 2020, 8(18): p. 5061-5070.
  15. Mukherjee, S.Kotcherlakota, R. et al. Silver Prussian blue analogue nanoparticles: rationally designed advanced nanomedicine for multifunctional biomedical applications. ACS Biomaterials Science & Engineering, 2019, 6(1): p. 690-704.
  16. Meka, R.R.Mukherjee, S., Patra, C.R.* and Chaudhuri, A.,* Shikimoyl-ligand decorated gold nanoparticles for use in ex vivo engineered dendritic cell based DNA vaccination. Nanoscale, 2019, 11(16): p. 7931-7943. (Equal Contributing First Author)
  17. Vemuri, S.K.,* Banala, R.R., Mukherjee, S., Uppula, P., Subbaiah, G.P.V.,...and Malarvilli, T.*, Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: Synthesis, biological evaluation, molecular modelling studies. Materials Science and Engineering: C, 2019, 99: p. 417-429.
  18. Kotcherlakota, R., Vydiam, K., Jeyalakshmi Srinivasan, D., Mukherjee, S., et al. Restoration of p53 function in ovarian cancer mediated by gold nanoparticle-based EGFR targeted gene delivery system. ACS Biomaterials Science & Engineering, 2019, 5(7): p. 3631-3644.
  19. Kotcherlakota, R., Nimushakavi, S., Roy, A., Yadavalli, H.C., Mukherjee, S., Haque, S. and Patra, C.R.* Biosynthesized gold nanoparticles: In vivo study of near-infrared fluorescence (NIR)-based bio-imaging and cell labeling applications. ACS Biomaterials Science & Engineering, 2019, 5(10): p. 5439-5452.
  20. Wei Wu, Jessica L Klockow, Suchismita Mohanty, Kimberly S Ku, Maryam Aghighi, Stavros Melemenidis, Zixin Chen, Kai Li, Goreti Ribeiro Morais, Ning Zhao, Jürgen Schlegel, Edward E Graves, Jianghong Rao, Paul M Loadman, Robert A Falconer, Sudip Mukherjee, Frederick T Chin, Heike E Daldrup-Link. Theranostic nanoparticles enhance the response of glioblastomas to radiation. Nanotheranostics, 2019, 3(4): p. 299.
  21. Chowdhury, S.R.Mukherjee, S., Das, S., Patra, C.R.* and Iyer, P.K.,* Multifunctional (3-in-1) cancer theranostics applications of hydroxyquinoline-appended polyfluorene nanoparticles. Chemical science, 2017, 8(11): p. 7566-7575. (Equal Contributing First Author)
  22. Muthuraj, B.Mukherjee, S., Chowdhury, S.R., Patra, C.R.* and Iyer, P.K.,* An efficient strategy to assemble water soluble histidine-perylene diimide and graphene oxide for the detection of PPi in physiological conditions and in vitro. Biosensors and Bioelectronics, 2017, 89: p. 636-644.
  23. Kumar, R., Das, S., Mukherjee, S., Bhosale, R.S.,* Patra, C.R.* and Narayan, R.,* Novel tetraphenylethylene diol amphiphile with aggregation-induced emission: self-assembly, cell imaging and tagging property. Materials Science and Engineering: C, 2017, 81: p. 580-587.
  24. Kotcherlakota, R., Srinivasan, D.J., Mukherjee, S., et al. Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer. Journal of Materials Chemistry B, 2017, 5(34): p. 7082-7098.
  25. Gaddam, R.R., Mukherjee, S., Punugupati, N., Vasudevan, D., Patra, C.R.,* Narayan, R.* and Kothapalli, R.V.* Facile synthesis of carbon dot and residual carbon nanobeads: Implications for ion sensing, medicinal and biological applications. Materials Science and Engineering: C, 2017, 73: p. 643-652. (Equal Contributing First Author) 
  26. Balakrishnan, S., Mukherjee, S., Das, S., Bhat, F.A., Raja Singh, P., Patra, C.R.* and Arunakaran, J.,*  Gold nanoparticles–conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt–mediated pathway in breast cancer cell lines (MCF‐7 and MDA‐MB‐231). Cell biochemistry and function, 2017, 35(4): p. 217-231.
  27. Mukherjee, S*, Das, S., Nuthi, S., and Patra, C.R.* Biocompatible nickel-prussian blue@silver nanocomposites show potent anti-bacterial activities. Future Science OA, 2017, 3(4): p. FSO233. [*Corresponding author]  
  28. Muthuraj, B.Mukherjee, S., Patra, C.R.,* Iyer, P.K.* Amplified Fluorescence from Polyfluorene Nanoparticles with Dual state Emission and Aggregation-Caused Red Shifted Emission for Live Cell Imaging and Cancer Theranostics. ACS Appl. Mater. Interfaces, 2016, 8(47): p. 32220–32229. (Equal Contributing First Author) 
  29. Mukherjee, S.Sau, S.Madhuri, D., et al. Green synthesis and Characterization of monodispersed gold nanoparticles: Toxicity study, delivery of doxorubicin & its bio-distribution in mice model. Journal of Biomedical Nanotechnology, 2016, 12: p. 165-181. 
  30. Agarwalla, P., Mukherjee, S., Sreedhar, B., Banerjee, R.* Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for EMT-reversal and tumor regression. Nanomedicine, 2016, 11: p. 2529-2546. 
  31. Balakrishnan, S. Bhat, F.A., Singh, P. R., Mukherjee, S., et al. Gold nanoparticle–conjugated quercetin inhibits epithelial–mesenchymal transition, angiogenesis, and invasiveness via EGFR/VEGFR‐2‐mediated pathway in breast cancer. Cell Proliferation, 2016, 49(6): p. 678-697.
  32. Mukherjee, S.Rao, B.R., Sreedhar, B., Paik, P. and Patra, C.R.* Copper Prussian blue analogue: Investigation for multifunctional activities in biomedical applications. Chem. Comm., 2015, 51(34): p. 7325-7328 
  33. Mukherjee, S., et al. Graphene oxides show angiogenic properties. Adv. Healthcare Mater., 2015, 4(11): p. 1722-32. 
  34. Mukherjee, S., Dasari, M., Priyamvada, S., Kotcherlakota, R., Bollu, V.S., Patra, C.R.* Biosynthesized gold nanoconjugates induces the inhibition of cancer cells proliferation through induction of oxidative stress and their in vivo toxicity study. J. Mater. Chem. B, 2015, 3: p. 3820-3830. 
  35. Patra, S.Mukherjee, S., Barui, A.K., Ganguly, A., Sreedhar, B. and Patra, C.R.* Green synthesis, characterization of gold and silver nanoparticles and their potential application for cancer therapeutics. Materials Science and Engineering C., 2015, 53: p. 298-309. (Equal Contributing First Author) 
  36. Muthuraj, B., Chowdhury, S.R, Mukherjee, S., Patra, C.R.* and Iyer, P.K.* Aggregation Deaggregation Influenced selective and sensitive detection detection of Cu2+ and ATP by Histidine Functionalized Water-Soluble Fluorescent PeryleneDiimide under Physiological Conditions and in Living Cells. RSC Adv., 2015, 5: p. 28211-28218.
  37. Mukherjee, S., et al. Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system). Theranostics, 2014, 4(3): p. 316-335. 
  38. Nethi, S.K., Mukherjee, S., Veeriah, V., Barui, A.K., Chatterjee, S., Patra, C.R.* Bioconjugated gold nanoparticles accelerate the growth of new blood vessels through redox signaling. Chem. Comm., 2014, 50: p. 14367-14370. 
  39. Sau, S., Agarwalla, P., Mukherjee, S., et al. Cancer Cell-Selective Promoter Recognition Accompanies Antitumor Effect by Glucocorticoid Receptor-Targeted Gold Nanoparticle. Nanoscale, 2014, 6: p. 6745-6754. 
  40. Pooja, D., Kulhari, H., Singh, M.K., Mukherjee, S., Rachamalla, S.S., Sistla, R.* Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes. Colloids Surf B Biointerfaces, 2014, 121: p. 461-8.
  41. Mukherjee, S., Vinothkumar, B., Prashanthi, S., Bangal, P.R., Sreedhar, B. and Patra, C.R.* Potential therapeutic and diagnostic applications of one-step in situ biosynthesized gold nanoconjugates (2-in-1system) in cancer treatment. RSC Adv., 2013, 3(7): p. 2318–2329.
  42. Mukherjee, S., et al. Green chemistry approach for the synthesis and stabilization of biocompatible gold nanoparticles and their potential applications in cancer therapy. Nanotechnology, 2012, 23(45): 455103.  
  43. Barui, A.K., Veeriah, V., Mukherjee, S., et al. Zinc oxide nanoflowers make new blood vessels. Nanoscale, 2012, 4: p. 7861-7869.

Review articles: 

  1. Faizan Ahmad, Anik Karan, Rashi Sharma, Navatha Shree Sharma, Vaishnavi Sundar, Richard Jayaraj, Sudip Mukherjee, Mark A. DeCoster. Evolving Therapeutic Interventions for the Management and Treatment of Alzheimer’s Disease. Ageing Research Reviews, 2024, DOI: 10.1016/j.arr.2024.102229.
  2. Boram Kim,# Lipi Pradhan,# Andrea Hernandez, Devyani Yenurkar, Susheel Kumar Nethi, Sudip Mukherjee*. Current advances in immunomodulatory biomaterials for cell therapy and tissue engineering. Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300002. [*Corresponding author]
  3. Devyani Yenurkar, Malay Nayak and Sudip Mukherjee*. Recent advances of Nanocrystals in Cancer theranostics. Nanoscale Advances, 2023, DOI: 10.1039/D3NA00397C. [*Corresponding author]
  4. S Patra, M Singh, K Wasnik, D Pareek, PS Gupta, S Mukherjee, P Paik. Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement. ACS Applied Bio Materials, (2022), 4 (10), 7342-7365.
  5. Vijay Sagar Madamsetty, Manash K Paul, Anubhab Mukherjee*Sudip Mukherjee*. Functionalization of nanomaterials and their application in melanoma cancer theranostics. ACS Biomaterials Science & Engineering, (2020), 6 (1), 167-181. [*Corresponding author
  6. Muhammad Ovais, # Sudip Mukherjee, # Arindam Pramanik, Devlina Das, Anubhab Mukherjee, Abida Raza, Chunying Chen. Designing Stimuli‐Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment. Advanced Materials, (2020), 32, 2000055. [# Equal Contribution]
  7. Sudip Mukherjee*, Madamsetty. Vijay Sagar, Dwaipayan Bhattacharya, Sayan Roy Chowdhury, Manash Kumar Paul*, Anubhab Mukherjee*. Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics. Advanced Functional Materials, (2020), 30, 2003054. [*Corresponding author]
  8. A Mukherjee, VS Madamsetty, MK Paul*S Mukherjee*. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer. International Journal of Molecular Sciences, (2020), 21 (455), 1-29. [*Corresponding author]
  9. S Mukherjee, L Liang, O Veiseh. Recent Advancements of Magnetic Nanomaterials in Cancer Therapy. Pharmaceutics, (2020), 12 (147), 1-18.
  10. M Ovais, SK Nethi, S Ullah, I Ahmad, S Mukherjee, C Chen. Recent advances in the analysis of nanoparticle-protein coronas. Nanomedicine, (2020). 15(10):1037-61.
  11. Mukherjee, Anubhab, Manash Paul, and Mukherjee S*. Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer. Cancers 11, no. 5 (2019): 597. [*Corresponding author] [From Special Issue "Cancer Nanomedicine"]
  12. Nethi, Susheel Kumar, Sourav Das, Chitta Ranjan Patra, and Mukherjee S*. Recent advances in inorganic nanomaterials for wound-healing applications. Biomater. Sci., (2019), 7, 2652-2674. [*Corresponding author]
  13. Nethi, Susheel Kumar#, Ayan Kumar Barui#Sudip Mukherjee#, and Chitta Ranjan Patra. Engineered Nanoparticles for Effective Redox Signaling During Angiogenic and Antiangiogenic Therapy. Antioxidants & redox signaling 30, no. 5 (2019): 786-809. [#Equal Contribution]
  14. S Mukherjee, D Sonanini, A Maurer, HE Daldrup-Link. The yin and yang of imaging tumor associated macrophages with PET and MRI. Theranostics, (2019) (25), 7730-7748.
  15. Vijay Sagar Madamsetty, Anubhab Mukherjee, Sudip Mukherjee*. Recent Trends of the Bio-inspired Nanoparticles in Cancer Theranostics Journal: Frontiers in Pharmacology, section Translational Pharmacology, (2019), 10, 1264. [*Corresponding author]
  16. Ovais, Muhammad, Ali Talha Khalil, Nazar Ul Islam, Irshad Ahmad, Muhamamd Ayaz, Muthupandian Saravanan, Zabta Khan Shinwari, and Sudip Mukherjee*. Role of plant phytochemicals and microbial enzymes in biosynthesis of metallic nanoparticles. Applied microbiology and biotechnology 102, no. 16 (2018): 6799-6814. [*Corresponding author]
  17. Ovais, Muhammad, Ali Khalil, Muhammad Ayaz, Irshad Ahmad, Susheel Nethi, and Sudip Mukherjee*. Biosynthesis of metal nanoparticles via microbial enzymes: a mechanistic approach. International journal of molecular sciences 19, no. 12 (2018): 4100. [*Corresponding author]  
  18. Muhammad Ovais, Irshad Ahmad, Ali Talha Khalil, Sudip Mukherjee, Rabia Javed, Muhammad Ayaz, Abida Raza, Zabta Khan Shinwari. Wound healing applications of biogenic colloidal silver and gold nanoparticles: recent trends and future prospects. Applied microbiology and biotechnology 102 (10), 4305-4318 (2018).  
  19. Mukherjee S, and Patra CR. Therapeutic application of anti-angiogenic nanomaterials in cancers. Nanoscale, 8, 12444–12470 (2016). From themed collection: Nanoscale approaches for cancer diagnosis and treatment.


  1. Sudip Mukherjee,* Arindam Pramanik, * Subrata Kumar Pore.* Immunomodulatory Nanomaterials in Cancer Theranostics, Frontiers in Chemistry, (2021), 9: 691267. [*Corresponding author]
  2. Mukherjee, Sudip. "Recent progress toward antiangiogenesis application of nanomedicine in cancer therapy." Future Science OA, (2018): FSO318. [*Corresponding author]  
  3. Mukherjee S*, Patra CR. Biologically synthesized metal nanoparticles: recent advancement and future perspectives in cancer theranostics. Future Science OA, FSO203 (2017). [*Corresponding author]
  4. Patra CR, Mukherjee S & Kotcherlakota R. Biosynthesized silver nanoparticle: a step forward for cancer theranostics? Nanomedicine, 5, 28211-28218 (2014).


  1. Mukherjee S*. Recent Advances in Innovative Magnetic Nanomaterials for Cancer Theranostics. 2019, Morgan & Claypool Publishers, Online ISBN: 978-1-64327-786-8 • Print ISBN: 978-1-64327-783-7, https://doi.org/10.1088/2053-2571/ab41ef. [*Corresponding author]
  2. Biogenic nanoparticles for cancer theranostics. Edited by Chittaranjan Patra, Irshad Ahmad, Muhammad Ayaz, Ali Talha Khalil, Sudip Mukherjee, and Muhammad Ovais. Elsevier, Micro & Nano Technologies Series, 2021, Elsevier, ISBN 978-0-12-821467-1, https://doi.org/10.1016/C2019-0-02790-2. [As Editor]
  3. A Mukherjee, VS Madamsetty, S Mukherjee*, Emerging trends in immunomodulatory nanomaterials towards cancer therapy. 2021, Springer Nature, Synthesis Lectures on Biomedical Engineering, eBook ISBN 978-3-031-01669-1, https://doi.org/10.1007/978-3-031-01669-1. [*Corresponding author]
  4. S Mukherjee*, VS Madamsetty. Nanoparticles in Angiogenesis and Cancer. 2022, Springer Nature, Synthesis Lectures on Biomedical Engineering (SLBE) series, eBook ISBN 978-3-031-11284-3, https://doi.org/10.1007/978-3-031-11284-3. [*Corresponding author]
  5. Sudip Mukherjee,* Boram Kim, Andrea Hernandez. Immunomodulatory Biomaterials for Cell Therapy and Tissue Engineering. 2024, Springer Nature, Synthesis Lectures on Biomedical Engineering (SLBE) series, eBook ISBN 9978-3-031-50844-8, https://link.springer.com/book/9783031508431. [*Corresponding author]

Book Chapter: 

  1. Mukherjee S, Nethi SK, Patra CR. Green synthesized gold nanoparticles for future biomedical applications. Book Title-„Particulate Technology for Delivery of Therapeutics‟. Editor: Sougata Jana & Subrata Jana, Springer publisher, 2017. DOI: https://doi.org/10.1007/978-981-10-3647-7_11.
  2. Mukherjee S,ǂ Rao BR,ǂ Kotcherlaota R,ǂ Patra CR. Prussian blue nanoparticles for cancer theranostic. Book Title-Prussian blue nanoparticles and nanocomposites: Synthesis, devices and applications. Editor: Yannick Guari & Joulia Larionova, Pan Stanford and CRC Press (Taylor & Francis) publisher, 2016, eBook ISBN9780429024740 (#equal contribution).
  3. Mukherjee S*, Nethi SK*. Biological Synthesis of Nanoparticles using bacteria. Book title: Nanotechnology for agriculture, editor: Panpatte G. Deepak, Jhala Yogeshvari K, Springer publisher, 2019, DOI. 10.1007/978-981-32-9370-0. [*Corresponding author]
  4. Nethi, Susheel Kumar, Anubhab Mukherjee, and Mukherjee S*. "Biosynthesized Gold and Silver Nanoparticles in Cancer Theranostics." Handbook of Nanomaterials and Nanocomposites for Energy and Environmental Applications (2020): 1-15. https://doi.org/10.1007/978-3-030-11155-7_29-1. [*Corresponding author]
  5. Mukherjee S. Biosynthesized silver nanoparticles in cancer theranostics applications. InBiogenic Nanoparticles for Cancer Theranostics 2021 Jan 1 (pp. 141-152). Elsevier, Micro & Nano Technologies Series, 2021, Elsevier, ISBN 978-0-12-8214671, https://doi.org/10.1016/C2019-0-02790-2 [*Corresponding author]
  6. Abbas M, Ovais M, Mukherjee S, Ali A, Hanif M, Chen C. Nanotechnology for cancer drug design, delivery, and theranostics applications. InBiogenic Nanoparticles for Cancer Theranostics 2021 Jan 1 (pp. 1-26). Elsevier, ISBN 978-0-12-8214671, https://doi.org/10.1016/C2019-0-02790-2.
  7. Chakravarty S, Roy Chowdhury S, Mukherjee S*. AIE materials for cancer cell detection, bioimaging and theranostics. Progress in Molecular Biology and Translational Science. 2021; 185:19-44. DOI: 10.1016/bs.pmbts.2021.07.032. PMID: 34782105. [*Corresponding author]
  8. Lipi Pradhan, B. Mounika, and Sudip Mukherjee*. Plant Leaf-Based Compounds and Their Role in Nanomaterials Synthesis and Applications. 2023, Press: Springer Nature. A. Husen (ed.), Secondary Metabolites Based Green Synthesis of Nanomaterials and Their Applications, Smart Nanomaterials Technology, DOI: 10.1007/978-981-99-0927-8_11. [*Corresponding author]
  9. Kalyan Vydiam, Sudip Mukherjee*. 3D and 4D Nanocomposites. 2023, Book name: Advances in smart nanomaterials and their applications. Press: Elsevier, Edited by A Husen and KS Siddiqi, ISBN: 978-0-323-99546-7, DOI: https://doi.org/10.1016/B978-0-323-99546-7.00014-8. [*Corresponding author]
  10. Kalyan Vydiam, Sudip Mukherjee*. Smart Nanomaterials: Environmental safety, risks, legal issues, and managements. 2023, Book name: Advances in smart nanomaterials and their applications. Press: Elsevier, Edited by A Husen and KS Siddiqi, ISBN: 978-0-323-99546-7, DOI: https://doi.org/10.1016/B978-0-323-99546-7.00010-0. [*Corresponding author]
  11. Lipi Pradhan, Devyani Yenurkar, and Sudip Mukherjee*, Toxicity Assessment of Gold Ions and Gold Nanoparticles on Plant Growth. 2023, Press: Springer Nature Singapore Pte Ltd., A. Husen (ed.), Book Name: Nanomaterials and Nanocomposites Exposures to Plants, Smart Nanomaterials Technology, https://doi.org/10.1007/978-981-99-2419-6_8. [*Corresponding author]
  12. Kalyan Vydiam, Jalal Ahmad and Sudip Mukherjee*. Development of metal-polymer composite nanomaterials for diagnosis and phototherapy. 2024, Book: Organic Nanomaterials for Cancer Phototheranostics. Publisher: Elsevier Ltd. DOI: https://doi.org/10.1016/B978-0-323-95758-8.00010-1. [*Corresponding author]

Conference Proceedings:

  1. Pragya, Govarthan PK, Sinha K, Mukherjee S*, Agastinose Ronickom JF*, 2023. Differential Gene Expression Data Analysis of ASD Using Random Forest. CARING IS SHARING–EXPLOITING THE VALUE IN DATA FOR HEALTH AND INNOVATION, p.1047. DOI: 10.3233/shti230344 . [*Corresponding author]

Patent granted (India and US): 
1. Mukherjee S & Patra CR. Biocompatible polymer coated silver prussian blue nanoparticles (SPB-NPS: Ag3 [Fe (CN)6]). [Granted on, March 19, 2019, US: Filing No. # 15/049604, dated February 22-2016: Publication No: US20160243163A1, INDIA: Filing No. # 502/DEL/2015, dated February 23-2015 (0244NF2014)]. 

2. Kotcherlakota R, Mukherjee S, Patra CR & Gopal V. Gold nanoparticles-based new formulation for the delivery of drugs and nucleic acids for HER2+ cancer therapy. [Granted on, October 20, 2020, US10806715B2, WO2018078648A2, International application number: PCT/IN2017/050488, International Filing Date: 23 October 2017, INDIA: Filing No. # 201611036499 dated October 25-2016; Patent application number: 0202NF2016, India]
Patent filed (India and US): 
1. Omid Veiseh, Amanda Nash, Maria Ruocco, Sudip Mukherjee, Michael Doerfert, Samira Aghlara-Fotovat, David Zhang. ‘Implantable Constructs and Uses Thereof’. US Patent, Provisional application (2020), US20220313599A1, PCT/US2020/045471. Technology (LOCOcyte) is licensed to Avenge Bio, USA and currently under clinical trial (Phase I/II).

2. Omid Veiseh, Grigoryan, Bagrat, Sazer, Daniel Warren, Parkhideh, Siavash Sam, Jordan Miller, Sudip Mukherjee. Vascularizing devices and methods for implanted diagnostics and therapeutics. International Patent Application, U.S. Provisional Patent Application (2020). WO2020168327A1, PCT/US2020/018511. 

3. David Yu Zhang, Omid Veiseh, Ping Song, Siavash Parkhideh, Sudip Mukherjee, Maria Ruocco, Lauren Cheng, et al. Entitled “High throughput genetic barcoding and analysis methods”. U.S. Provisional Patent Application, (2020). WO2021146393A1, PCT/US2021/013395.

4. Sourav Das, Sudip Mukherjee, Chitta Ranjan Patra, Lysozyme assisted metal based Fluorescent Nanocomposites and its Biomedical Applications. PCT Application no. PCT/IN2021/050215 filed on 5 March 2021. Claiming Priority from Indian Patent Application No.: 202011009670 dated March 06, 2020. 

5. David Zhang, Ping Song, Omid Veiseh, Siavash Parkideh, Sudip Mukherjee, Maria Ruocco, Boram Kim, Michael Doerfert, Yuxuan Cheng. Triazole containing polymers and methods of use thereof. U.S. Provisional Patent Application. Filed on June 14th, 2021. WO2022266086A2, PCT/US2022/033416.

6. Omid Veiseh, Christian Schreib, Maria Ruocco, Tanguy Terleir, Sudip Mukherjee. "Identification of pro- and anti-inflammatory lipids relating to immune response to medical implants". U.S. Provisional Patent Application, filed with the USPTO on July 30, 2021. PCT/US2022/074312, WO2023010117A1.

7. Omid Veiseh, Samira Aghlara-Fotovat, Michael David Doerfert, Sudip Mukherjee, Amanda Nash, Maria Isabel Ruocco, David Zhang. Encapsulated Cells Expressing IL-2 and Uses Thereof. WO2023069993A1, US202163257891P. Technology (LOCOcyte) is licensed to Avenge Bio, USA and currently under clinical trial (Phase I/II).

8. Omid Veiseh, Christian Schreib, Sudip Mukherjee, Lizzy Kelley. 'A Wound Healing Device for Release of Therapeutics and Sensing'. U.S. Provisional Patent Application, filed with the USPTO on August 30, 2023. Application number: 63/520,231.

9. Omid Veiseh, Christian Schreib, Sudip Mukherjee, Lizzy Kelley. 'Wound Healing Devices for Directed Control of Therapeutic Agent Release'. U.S. Provisional Patent Application, filed with the USPTO on August 30, 2023. Application number: 63/520,243.

10. Omid Veiseh, Christian Schreib, Sudip Mukherjee, Lizzy Kelley. 'Wound Healing Devices for Sensing Infections'. U.S. Provisional Patent Application, filed with the USPTO on August 30, 2023. Application number: 63/520,250.

11. Omid Veiseh, Christian Schreib, Sudip Mukherjee, Lizzy Kelley. 'Devices Useful for Treatment of Closed Wounds'. U.S. Provisional Patent Application, filed with the USPTO on August 30, 2023. Application number: 63/520,252.

12. Omid Veiseh, Christian Schreib, Sudip Mukherjee. “A healing patch for electrochemical sensing, stimulation and controlled delivery of wound healing factors to wound bed.” U.S. Provisional Patent Application, filed with the USPTO on February 18, 2022. (2022), Rice Tech ID No. 2022-044.

Odd Semester:
Human Physiology (BO 202): 2022-23, 2023-24
Molecular Biology and genetics (BM 201): 2022-23
Biotransport Process (BM 421): 2022-23
PG Course: Physiology (BM 503): 2022-23, 2023-24

Even Semester:
Transport Process (BM 205): 2022-23
PG Course: Biomaterial Technology (BM 510): 2022-23, 2023-24.

Actively looking for motivated Postdocs (with fellowship)/Ph.D. (NPDF/CSIR/UGC/GATE/DBT/ICMR/Inspire fellows)/Masters/Undergraduate students to work in the field of Cell Engineering and Biomaterials based technologies for the treatment of Type-1 Diabetes, Cancer, Rare Genetic Disorders, Wound Healing and Fibrosis.

2018        Houston Methodist- Rice University Innovative Collaborative Travel Award.
2016        Young Scientist Award in Chemical Sciences in the year 2016 from KVRao Scientific Society, Hyderabad, India.
2016        Best Poster Award at international conference ‘Bangalore-India Nano’, Bangalore, India. Title: Graphene oxides develop new blood vessels by angiogenesis.
2015        Best Poster Award at international conference ‘ICANN-2015, IIT-Guwahati’, India. Title: Graphene oxides show angiogenic properties.
2016        Best Publication Award at CSIR-IICT in biological sciences at Annual Day Awards, CSIR-IICT, Hyderabad. Paper Title: Graphene oxides show angiogenic properties.
2011-17   CSIR Research Fellowship (JRF and SRF) from Council of Scientific and Industrial Research, India (All India Rank # 014).

2020-Present:   Member, Royal Society of Chemistry, UK (MRSC)

2024             :   Life Member, Society of Biomaterials and Artificial Organs, India

2024             :   Co-convenor, International conference TransMat-2k24 at IIT (BHU), Varanasi

2020-2021    :   Member, American Chemical Society, USA

2019-Present:   Associate Member, American Association for Cancer Research (AACR)

2021-Present:   Associate Editor, Frontiers in Chemistry (Section: Nanoscience)

2021-Present:   Associate Editor, BMC Cancer, UK

2017-Present:   International advisory board member, Materials Research Express, IOPScience, UK

2019-Present:   Guest Editor Cancers (MDPI); Biomedical Materials (IOP)

2017-Present:   Scientific Blog Writer, Biomaterials Science, RSC, UK

2012-16       :    Affiliate member, Royal Society of Chemistry, UK

2016-19       :    Associate Member, Royal Society of Chemistry, UK (AMRSC)

2012-Present:   Editorial Referee for journals: Biomaterials, Chemical Communications, Journal of Materials Chemistry A &    B, Cancers, Materials Science and Engineering C, Journal of Biomedical Nanotechnology, Int. Journal of Mol. Sc., Acta biomaterialia, IOP Nanotechnology, Biofabrication, Dalton Transaction, RSC Advances, Food and Function, Journal of photochemistry & photobiology, b: biology, Nature Scientific Reports, Pharmaceutics etc.

2019-Present:  Grant reviewer (National Science Centre Poland, Swiss Cancer Research foundation)

1. Oral presentation given at international conference at ICNANO-2013, Ansal University on July 25-26, 2013, Gurgaon for Young scientist category. Title: ‘Theranostics Applications of Biosynthesized Nanoparticles in Cancer.
2. Poster presentation given at international conference at ICANN-2013, IIT-Guwahati on Dec 1-3, 2013. Title: ‘Biosynthesized noble metal nanoparticles for cancer therapeutics and diagnostics.
3. Poster presentation given at international conference at ICCB-2014, CSIR-IICT on Feb 6-8, 2014. Title:‘Multifunctional biomedical applications of inorganic nanoparticles.’ This conference is first Society of Chemical Biology conferences held in INDIA.
4. Poster presentation given at international conference at ICANN-2015, IIT-Guwahati (Dec 8- 11). Title: ‘Graphene Oxides Show Angiogenic Properties. I was awarded with best poster award for my poster. 4th International Conference on Advanced Nanomaterial and Nanotechnology (ICANN-2015) is being organized by Centre for Nanotechnology at the Indian Institute of Technology Guwahati (IITG), India during Dec 8-11, 2015.
5. Poster presentation given at international conference at Bangalore-INDIA NANO-2016 (March 3-4), Bangalore. Title: ‘Graphene Oxides Develop New Blood Vessels by Angiogenesis.’ I was awarded with best poster awards at 8th Bangalore-India Nano conference organized in Bangalore, India for my poster The eighth edition of the three day event started from March 3 saw the participation of around 600 delegates.
6. Oral presentation given to receive Young Scientist Award in Chemical Sciences in the year 2016 from KVRao Scientific Society, Hyderabad, India for my presentation ‘Graphene Oxides Show Angiogenic Properties’ in Chemical Sciences category. Started in 2001, the event is held annually to promote scientific research and encourage young scientists to continue their career in basic sciences.
7. Poster presentation given at 2018 Nanomedicine and Drug Delivery Symposium (NanoDDS, Portland, OR, Sep 21-23, 2018), Portland, OR on ‘Smart modification of biomaterials surfaces with small molecules for modulation of host immune responses’.
8. Invited talk given during a webinar on “Covid 19-Life in United States as a Researcher and Therapeutic Advancements” on May 13, 2020 at 6:00 P.M. at the Electrical Engineering Department of Greater Kolkata College of Engineering and Management (JIS Group), Baruipur, Kolkata, West Bengal, India.
9. Invited talk given during a webinar on ‘COVID-19-The emergences and development of vaccination, alarming resurgence and potential prognostics’ at the Electrical Engineering Department of Greater Kolkata College of Engineering and Management (JIS Group), Baruipur, Kolkata, West Bengal, India (2021).
10. Invited talk given on ‘Application of Nanomaterials in Angiogenesis towards Cancer and Cardiovascular Disease’ at the webinar organized by department of bioengineering department, King Fahd University of Petroleum and Minerals, Saudi Arabia (2021).

11. Invited talk given on 'In vivo high-throughput screening using cellular barcoding allows discovery of biomaterials that prevents fibrosis' at 4th Biological Engineering Society National Conference – 2022 (BESCON-2022), at Bose Institute, Kolkata, West Bengal.

12. Invited talk given on 'In vivo screening of hydrogel library using cellular barcoding identifies biomaterials that mitigates host immune responses and fibrosis' at International Conference on Biomaterials, Regenerative Medicine and Devices (BIO-REMEDI 2022), at IIT Guwahati, Assam, India.

13. Invited talk given on 'Perfusable cell-laden 3D-printed hydrogel constructs to guide patterned vascularization in vivo' at International Workshop '3D-LITHO-2023' organized at IIT BOMBAY (April, 2023).

14. Invited talk given on 'In vivo high-throughput screening using cellular barcoding identifies hydrogels that mitigate fibrosis' at International Conference (Hybrid) 'ICNP-2023' organized by Mahatma Gandhi University, Kerala (May, 2023).

15. Invited talk given on 'Modification of materials surfaces with immunomodulatory small molecule reduces macrophage capture' at International Conference ICNBL-2023 organized by NIT-Srinagar and IIT (BHU) at Srinagar, Kashmir (May 2023).

16. Invited talk given on 'Modification of materials surfaces with immunomodulatory small molecule reduces macrophage capture and fibrosis' at International Conference AMBT-2023 organized by BHU at Varanasi (October 12, 2023).

17. Invited talk given on 'Immunoprotective Coating to Biomaterials Reduces Macrophage Recognition and Prevents Fibrosis' at International Workshop organized by Department of Pharmacology, IIT (BHU), Varanasi (October 27, 2023).

18. Talk given during visit at Niigata University at Sakura Exchange Program, Japan (November 24, 2023).


1. IIT (BHU) Institute Seed Grant: INR 10 Lakhs as PI. (2022-2023). Area of Research: Implantable Cell Therapy in Type-1 Diabetes. Status: Completed.

2. Research Fund from Royal Society of Chemistry, UK: GBP £4000 (INR 3.94 Lakhs) as PI. (2023-24, Grant Number: R22-2922732087, Duration: 1 year). Area of Research: Engineered Cell Therapy in Diabetic Wound Healing. Status: Ongoing.

3. Research Fund from Indian Council of Medical Research (ICMR): INR 32.645 Lakhs as PI. (2023, Proposal Number: 2023-19948/F1, Duration: 3 years). Area of Research: Engineered Cell Therapy in Gaucher's Disease. Status: Ongoing.

4. Research Fund from DBT, India: INR 21.796 Lakhs as PI. (2023; Proposal Number: BT/PR49530/MED/32/839/2023, Duration: 1 year 6 months). Area of Research: Engineered Cell Therapy in All Round Rapid Wound Repair (ARRWR) in Diabetic Wound. Status: Ongoing.

5. Research Fund from SERB (SRG), India: INR 29.44 Lakhs as PI. (2023; Proposal Number: SRG/2023/000409, Duration: 2 Years). Area of Research: An immunoprotective hydrogel-based implantable construct containing xenogeneic islets for type 1 diabetes therapy. Status: Ongoing.

6. Research Fund from MoE-STARS, IISC Bangalore: INR 67.60 Lakhs as CO-PI. (2023; Proposal Reference ID: MoE/STARS/2023-0318/2023-0318, Duration: 3 years). Area of Research: Implantable Cell-based Therapy in Intraperitoneal Cancers. Status: Ongoing.

7.  Research Fund from DBT, India: INR 24.42 Lakhs as CO-PI. (2023; Proposal Number: BT/PR49359/MED/32/897/2023, Duration: 1 year 8 months). Area of Research: Development of Zirconia-based Dental Ceramic Implant with Minimum Fibrosis. Status: Approved.

8. Research Fund from CRG, SERB: INR ~50 Lakhs as CO-PI. (2024; Proposal Reference ID: CRG/2023/005576, Duration: 3 years). Area of Research: Development of Implantable hydrogel based immunotherapeutic patch for Treatment of Oral cancer and associated microbial infections through Cell therapy approach. Status: Approved.

As Supervisor:

1. Lipi Pradhan (UGC-JRF; Ph.D. student)  

2. Malay Nayak (TA, GATE, Ph.D. student)

3. Anjali (UGC-JRF, Ph.D. student; Co-supervisor: Dr Kundan Kumar)

4. Devyani Yenurkar (PMRF, TA, Ph.D. student, Co-supervisor: Dr. Arnab Sarkar)

5. Sumit Manna (DBT-JRF; Ph.D. student)

6. Durba Banerjee (UGC-JRF; Ph.D. student)  

7. Snehasish Mandal (CSIR-JRF; Ph.D. student)  

As Co-Supervisor:

1. Shikha Tripathi (PMRF, Ph.D. student at Department of Physics, IIT (BHU); Supervisor: Dr. Avanish Parmar)

2. Pragya (CSIR-JRF, Ph.D. student at SBME, IIT (BHU); Supervisor: Dr. Jac Fredo)

M.Tech. and IDD:

1. Moumita Doloi (M.Tech.)

2. Sangeeta Kumari (M.Tech.)

3. Mounika (IDD)

4. Suyansh (IDD)

5. Anoushka Shrivastava (IDD)

6. Prajwal Kamath (IDD)

7. Bajrang (IDD)

8. Vivek Kumar (IDD)

Summer Interns:

1. Prince, 2. Lidiya, 3. Ankit, 4. Shruti, 5. Nikki, 6. Shreya, 7. Harshita

a)    Dept/Centre’s Level:

1.    Convenor of Annual Report 2022-23

2.    Convenor of Departmental Website Development 2022-23

3.    Member of DPGC 2022-23, 2023-24

4.    Member of DUGC 2023-24

5.    Member of Timetable committee 2022-23

6.    Member: M. Tech. and Ph.D. admissions 2022-23

7.    Member: Physical Verification of Fixed Asset/Audit (2022-23)

8.    Convenor: Timetable Committee and Examination in-charge (2023-2024)

b)    Institutes Level:

1. Member of Election Council, 2022-23 (Election Date: March 31st, 2023)

2. Faculty Mentor for Induction Mentorship Program, 2023

3. Co-convenor at International Conference TransMat2k24, IIT (BHU), Varanasi